0.4654
price down icon5.12%   -0.0251
after-market 시간 외 거래: .47 0.0046 +0.99%
loading
전일 마감가:
$0.4905
열려 있는:
$0.48
하루 거래량:
159.41K
Relative Volume:
0.42
시가총액:
$50.75M
수익:
$5.12M
순이익/손실:
$-67.00M
주가수익비율:
-0.3166
EPS:
-1.47
순현금흐름:
$-38.94M
1주 성능:
-15.83%
1개월 성능:
-16.59%
6개월 성능:
-70.36%
1년 성능:
-93.33%
1일 변동 폭
Value
$0.4395
$0.4804
1주일 범위
Value
$0.4369
$0.5898
52주 변동 폭
Value
$0.3816
$11.41

Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile

Name
명칭
Verrica Pharmaceuticals Inc
Name
전화
484-453-3300
Name
주소
10 NORTH HIGH STREET, WEST CHESTER, PA
Name
직원
71
Name
트위터
Name
다음 수익 날짜
2025-03-11
Name
최신 SEC 제출 서류
Name
VRCA's Discussions on Twitter

VRCA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
VRCA
Verrica Pharmaceuticals Inc
0.4654 50.75M 5.12M -67.00M -38.94M -1.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-11-06 다운그레이드 H.C. Wainwright Buy → Neutral
2024-11-05 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2023-07-25 업그레이드 Needham Hold → Buy
2023-03-22 개시 Jefferies Buy
2023-02-13 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2022-05-25 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2021-05-14 개시 RBC Capital Mkts Outperform
2020-12-24 재확인 H.C. Wainwright Buy
2020-07-15 다운그레이드 BofA Securities Buy → Neutral
2020-06-30 재확인 H.C. Wainwright Buy
2020-06-24 개시 Northland Capital Outperform
2020-03-24 개시 Needham Buy
2019-02-21 개시 H.C. Wainwright Buy
모두보기

Verrica Pharmaceuticals Inc 주식(VRCA)의 최신 뉴스

pulisher
Apr 18, 2025

GLP-1 Receptor Agonist Market Is Booming Worldwide 2025-2032: Verrica Pharmaceuticals, AbbVie Inc. - newstrail.com

Apr 18, 2025
pulisher
Apr 18, 2025

Leadership Changes at Madrigal Pharmaceuticals Mark New Phase of Growth - MyChesCo

Apr 18, 2025
pulisher
Apr 13, 2025

Verrica Pharmaceuticals Appoints Dr. Noah Rosenberg as Chief Medical Officer - MSN

Apr 13, 2025
pulisher
Apr 13, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Earns "Neutral" Rating from HC Wainwright - MarketBeat

Apr 13, 2025
pulisher
Apr 11, 2025

New Drug Application Submitted in Japan for Verrica Pharmaceuticals’ TO-208 - MSN

Apr 11, 2025
pulisher
Apr 11, 2025

Needham & Company LLC Reiterates “Hold” Rating for Verrica Pharmaceuticals (NASDAQ:VRCA) - Defense World

Apr 11, 2025
pulisher
Apr 11, 2025

HC Wainwright Analysts Decrease Earnings Estimates for VRCA - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

What is HC Wainwright’s Forecast for VRCA FY2028 Earnings? - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Receives “Neutral” Rating from HC Wainwright - Defense World

Apr 09, 2025
pulisher
Apr 09, 2025

Verrica Pharmaceuticals Reports Strong First-Quarter Growth for YCANTH - MSN

Apr 09, 2025
pulisher
Apr 09, 2025

H.C. Wainwright maintains Neutral on Verrica stock after Q1 update By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 08, 2025

Verrica Pharmaceuticals at Needham Conference: Strategic Restructuring and Growth By Investing.com - Investing.com Canada

Apr 08, 2025
pulisher
Apr 07, 2025

In face of U.S. stock market selloff, shares of West Chester firm are on the rise - The Business Journals

Apr 07, 2025
pulisher
Apr 07, 2025

Verrica Pharmaceuticals Reports Strong Demand-Led Growth In Ycanth® In Q1 2025 - marketscreener.com

Apr 07, 2025
pulisher
Apr 07, 2025

Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Dispensed Applicator Units in First Quarter 2025 - The Manila Times

Apr 07, 2025
pulisher
Apr 07, 2025

Verrica Pharmaceuticals Reports Strong Demand-Led Growth in - GlobeNewswire

Apr 07, 2025
pulisher
Apr 07, 2025

Record-Breaking Quarter: YCANTH Crosses 10K Units Milestone with 17% Growth - Stock Titan

Apr 07, 2025
pulisher
Apr 05, 2025

Verrica Pharmaceuticals Adds Dr. Gavin Corcoran to Board of Directors - MSN

Apr 05, 2025
pulisher
Apr 03, 2025

Here's Why Verrica Pharmaceuticals (VRCA) Is a Great 'Buy the Bottom' Stock Now - MSN

Apr 03, 2025
pulisher
Apr 03, 2025

Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors - The Manila Times

Apr 03, 2025
pulisher
Apr 03, 2025

Verrica Pharmaceuticals appoints new board member - Investing.com Australia

Apr 03, 2025
pulisher
Apr 02, 2025

Verrica Pharmaceuticals appoints new board member By Investing.com - Investing.com Canada

Apr 02, 2025
pulisher
Apr 02, 2025

Palvella Therapeutics Announces Late-Breaking Presentation at Global Pediatric Dermatology Congress - MyChesCo

Apr 02, 2025
pulisher
Apr 02, 2025

Verrica Pharmaceuticals expands board with new director By Investing.com - Investing.com Canada

Apr 02, 2025
pulisher
Apr 02, 2025

Verrica Pharmaceuticals Appoints Dr. Corcoran as Director - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Verrica Pharmaceuticals expands board with new director - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Strategic Move: Verrica Adds Formation Bio CDO to Board Amid YCANTH Success - Stock Titan

Apr 02, 2025
pulisher
Apr 02, 2025

Verrica Pharmaceuticals to Present at Needham Healthcare Conference - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

Palvella Therapeutics Reports 2024 Financial Results and Advances Rare Disease Pipeline - MyChesCo

Apr 02, 2025
pulisher
Apr 01, 2025

Harmony, Lungpacer, Verrica and Arbutus make C-suite hires - The Business Journals

Apr 01, 2025
pulisher
Mar 31, 2025

Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Exclusive: Verrica Pharmaceuticals CEO Fireside Chat at Major Healthcare Conference - Stock Titan

Mar 31, 2025
pulisher
Mar 26, 2025

Verrica Pharmaceuticals appoints new CMO to advance skin treatments By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Verrica Pharmaceuticals appoints Rosenberg as CMO - MSN

Mar 26, 2025
pulisher
Mar 26, 2025

Verrica Pharmaceuticals appoints new CMO to advance skin treatments - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Dermatology Drug Pioneer Joins Verrica to Accelerate YCANTH Growth - Stock Titan

Mar 26, 2025
pulisher
Mar 25, 2025

VRCA stock plunges to 52-week low, touches $0.5 - Investing.com

Mar 25, 2025
pulisher
Mar 19, 2025

Verrica Pharmaceuticals Inc (VRCA)’s stock price range in the last year - US Post News

Mar 19, 2025
pulisher
Mar 18, 2025

Verrica Pharmaceuticals Reports Positive Q4 2024 Results - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Verrica Pharmaceuticals’ chief legal officer sells shares for $2,804 By Investing.com - Investing.com South Africa

Mar 18, 2025

Verrica Pharmaceuticals Inc (VRCA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
자본화:     |  볼륨(24시간):